| Element List | Explanation |
|---|---|
| Announcement Detail | Al Hammadi Holding Company announces that Sudair Pharmaceutical Company – a closed joint stock company and one of Al Hammadi Holding affiliate companies, in which Al Hammadi Holding owns 35% of the shares – has submitted its application file to the Capital Market Authority for the registration and offering of its shares for an initial public offering (IPO) on the Main Market, and its application file to the Saudi Exchange (Tadawul) for the listing of its shares, in order to complete the regulatory requirements necessary for the offering.Any material developments will be announced in due course. |